259 related articles for article (PubMed ID: 28461360)
1. Mongolia's Public Spending On Noncommunicable Diseases Is Similar To The Spending Of Higher-Income Countries.
Dugee O; Munaa E; Sakhiya A; Mahal A
Health Aff (Millwood); 2017 May; 36(5):918-925. PubMed ID: 28461360
[TBL] [Abstract][Full Text] [Related]
2. Who is bearing the financial burden of non-communicable diseases in Mongolia?
Dugee O; Palam E; Dorjsuren B; Mahal A
J Glob Health; 2018 Jun; 8(1):010415. PubMed ID: 29564086
[TBL] [Abstract][Full Text] [Related]
3. Economic impacts of chronic conditions in a country with high levels of population health coverage: lessons from Mongolia.
Dugee O; Sugar B; Dorjsuren B; Mahal A
Trop Med Int Health; 2019 Jun; 24(6):715-726. PubMed ID: 30870575
[TBL] [Abstract][Full Text] [Related]
4. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
[TBL] [Abstract][Full Text] [Related]
5. Consumption displacement in households with noncommunicable diseases in Bangladesh.
Datta BK; Husain MJ; Fatehin S; Kostova D
PLoS One; 2018; 13(12):e0208504. PubMed ID: 30543648
[TBL] [Abstract][Full Text] [Related]
6. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
[TBL] [Abstract][Full Text] [Related]
7. Comparative financing analysis and political economy of noncommunicable diseases.
Jakovljevic M; Jakab M; Gerdtham U; McDaid D; Ogura S; Varavikova E; Merrick J; Adany R; Okunade A; Getzen TE
J Med Econ; 2019 Aug; 22(8):722-727. PubMed ID: 30913928
[TBL] [Abstract][Full Text] [Related]
8. A review on Noncommunicable Diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India.
Kundu MK; Hazra S; Pal D; Bhattacharya M
Indian J Public Health; 2018; 62(4):302-304. PubMed ID: 30539894
[TBL] [Abstract][Full Text] [Related]
9. Equity in distribution of public subsidy for noncommunicable diseases among the elderly in India: an application of benefit incidence analysis.
Bose M; Banerjee S
BMC Public Health; 2019 Dec; 19(1):1735. PubMed ID: 31878911
[TBL] [Abstract][Full Text] [Related]
10. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
[TBL] [Abstract][Full Text] [Related]
11. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
[TBL] [Abstract][Full Text] [Related]
12. Noncommunicable Disease Prevention and Control in Mongolia: A Policy Analysis.
Chimeddamba O; Peeters A; Walls HL; Joyce C
BMC Public Health; 2015 Jul; 15():660. PubMed ID: 26169789
[TBL] [Abstract][Full Text] [Related]
13. Impact of ill-health on household consumption in Sri Lanka: Evidence from household survey data.
Kumara AS; Samaratunge R
Soc Sci Med; 2017 Dec; 195():68-76. PubMed ID: 29154182
[TBL] [Abstract][Full Text] [Related]
14. National health expenditures: a global analysis.
Murray CJ; Govindaraj R; Musgrove P
Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
[TBL] [Abstract][Full Text] [Related]
15. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
[TBL] [Abstract][Full Text] [Related]
16. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.
Subramanian S; Gakunga R; Kibachio J; Gathecha G; Edwards P; Ogola E; Yonga G; Busakhala N; Munyoro E; Chakaya J; Ngugi N; Mwangi N; Von Rege D; Wangari LM; Wata D; Makori R; Mwangi J; Mwanda W;
PLoS One; 2018; 13(1):e0190113. PubMed ID: 29304049
[TBL] [Abstract][Full Text] [Related]
17. Basic patterns in national health expenditure.
Musgrove P; Zeramdini R; Carrin G
Bull World Health Organ; 2002; 80(2):134-42. PubMed ID: 11953792
[TBL] [Abstract][Full Text] [Related]
18. How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts.
Wieser S; Riguzzi M; Pletscher M; Huber CA; Telser H; Schwenkglenks M
Eur J Health Econ; 2018 Nov; 19(8):1149-1161. PubMed ID: 29470673
[TBL] [Abstract][Full Text] [Related]
19. Public expenditure on Non-Communicable Diseases & Injuries in India: A budget-based analysis.
Gupta I; Ranjan A
PLoS One; 2019; 14(9):e0222086. PubMed ID: 31513623
[TBL] [Abstract][Full Text] [Related]
20. Health care financing and delivery in developing countries.
Schieber G; Maeda A
Health Aff (Millwood); 1999; 18(3):193-205. PubMed ID: 10388216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
